Babel Health Experiences Dynamic Growth Q218

Babel Health Experiences Dynamic Growth in Q2 2018

PITTSBURGH (PRWEB) July 31, 2018

Babel Health, LLC, an innovative provider of an integrated, compliant ETL-based SaaS suite of data management and encounter submission software and services to government health plans, is pleased to announce exceptional growth in the second quarter of 2018. In addition to signing two new clients, Babel Health closed a round of funding totaling $2.45 million and added new staff to support its strategic initiatives.

The financing round includes $1 million in follow-on investments by existing investors, Babel management and founders, as well as $1.5 million from new individual investors and three investment groups: NueCura, 535 Smithfield Partners and Winter Street Ventures. The funds will be used to accelerate product development, maintain world class customer support and ramp up Babel’s already active sales velocity. The raise is a strong validation of the Babel company and product strategy.

“Babel’s extraordinary technology provides an elegant solution for the new challenges faced by health plans in the claims risk adjustment submission process,” stated Don Lazas, MD, Managing Partner of NueCura Partners, LLC. “The company’s superb business and technology leadership and customer-focused strategy are driving accelerated product adoption and capture of market share.”

To support this dynamic growth, Babel Health has hired six new employees in the last six weeks, including a Director of EDI & Configuration, Sr. Developer, Sr. Project Manager, QA Lead, two System Business Analysts and a Sales & Marketing Associate.

“Babel is proud to attract the best and brightest in our industry,” stated Robert Dunn, Babel’s CEO. “Our latest hires have added immediate value and allowed us to sustain our rapid growth while continuing to provide high quality software and services to the government sponsored health plans.”

To learn more about Babel, visit http://www.babelhealth.com.

###

ABOUT BABEL HEALTH, LLC

Babel Health provides an innovative, customer-focused approach to the entire risk adjustment submission process for health plans. The company’s integrated SaaS ETL (extract-transform-load) data management platform provides health plans with full transparency and control of the underlying data for business insight and critical day-to-day business decision making across all lines of business. Unlike other solutions in the marketplace, Babel enables its customers to take control of an extraordinarily complex process and provides user-friendly access to the data in order to solve the business problems inherent to risk adjustment submissions. In addition, the Babel team is committed to continually improving our customer’s experience through product enhancements, streamlined processes, clear communication and ethical interactions.

###

ABOUT NUECURA PARTNERS, LLC

NueCura Partners, LLC is a Nashville-based angel investment group that focuses on early-stage investment opportunities in the healthcare sector. NueCura is managed by seasoned healthcare business operators and leverages their experience to identify and finance breakthrough technologies and services in the healthcare space. http://www.nuecura.com

NueCura Partners, LLC Invests in RxREVU

NASHVILLE, Tenn., Apr. 22, 2015 /PRNewswire-iReach/ — NueCura Partners, LLC has added the rapidly growing Denver based start-up, RxREVU, to its portfolio. “We’re tremendously excited to partner with RxREVU. Their software represents an extraordinary new approach to prescribing, and will greatly assist doctors and patients in finding the right medication at the right price,” says Ted Sanft, Operating Partner at NueCura.

RxREVU helps consumers and providers find the best drugs available based on cost, condition, and clinical research. Their mission is to help people live happier and healthier lives by finding the most effective treatment at the lowest cost. The company is trail-blazing the use of predictive analytics to help analyze medications based on unique patient factors, such as age, gender and ethnicity.

“Working with NueCura Partners was a great experience all around. Their team brings a deep understanding of the healthcare industry and clearly understands the need for our technology,” said Carm Huntress, CEO of RxREVU, Inc. “We’ve met with many early stage investment groups and could not be more impressed with the partners’ backgrounds, connectivity to the Nashville healthcare community and support they’ve already given us as an early stage company” said Huntress.

NueCura Partners, LLC is a Nashville-based angel investment group that focuses on early-stage investment opportunities in the healthcare sector. NueCura is managed by seasoned healthcare business operators and leverages their experience to identify and finance breakthrough technologies in the healthcare space. You can learn more about RxREVU at www.rxrevu.com.

Media Contact: Susan Francisco, RxREVU, Inc., (800) 360-4965, susan.francisco@rxrevu.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE RxREVU

NueCura Partners, LLC: “Investing in the New Age of Healthcare”

We launched NueCura Partners, LLC with the goal of addressing an unmet need in the Nashville investment community. There are many experienced business and healthcare operators who have an interest in investing in early-stage healthcare businesses, but don’t have the time, expertise or confidence to identify and evaluate good opportunities. NueCura is attempting to change this paradigm.

Nashville is flush with traditional venture capital companies that offer excellent investment opportunities. However, the typical VC model requires front and back end fees and the fund managers control all investment decisions. Alternatively, there are a few local angel investment companies but these also have fee requirements and are not healthcare specific.

NueCura Partner’s offers another option. We are an affiliated angel investor model where each member makes their own investment decision following group and individual deal due diligence. NueCura focuses specifically on investments in the healthcare sector. We consider the full spectrum of healthcare-related businesses with the exception of biopharmaceuticals and implantable medical devices (beyond 510K approval).

NueCura Partners has taken capital positions in several well known offerings including Diatherix Laboratories, NextGxDx, and LeanKit. We are also participating in the upcoming Series A round financing for InvisionHeart. The Nashville investment community has been very receptive to NueCura Partners and the professionalism and expertise we bring to the financing process for early-stage companies. We are excited for our opportunity and for the potential we have to favorably impact new healthcare businesses in Nashville. We are investing in the ‘new age’ of healthcare!

NueCura: Proud Partner of Jumpstart Foundry

Jumpstart Foundry, a local Nashville business accelerator, was recently ranked in the top 15 of the countries best accelerators. Companies were ranked based on the valuations of their portfolio companies achieved in the years after graduation.

NueCura Partners is a proud supporter of JSF. We have invested in NextGxDx, JSF class of 2010 alumnus, and we are poised for our Series A Round investment in InvisionHeart from the graduating class of 2013.

Jumpstart Foundry is a 14-week, mentor-driven business acceleration program culminating in the launch of successful startups which are showcased at Investor Day. JSF has graduated over 30 companies since its inception in 2010 and has over 100 diverse business mentors participating in the program. Vic Gatto, founder of JSF, says his goal is to place in the top five US business accelerators within the next few years.

As a representative of NueCura Partners, I have had the honor of participating as a Mentor for JSF and this year my involvement will also include being a member of the Selection Committee for the incoming class of 2014 as well as participating in the new Investor Mentor program.